Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity
The American Journal of Pathology · 2026-09
DOI: 10.1016/j.ajpath.2026.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-09. Verfasst von Maria A Zambrano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Graduate Program, Tufts University Graduate School of Biomedical Sciences, Boston, Massachusetts; Department of Microbiology and Immunolog…. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Heart Lung and Blood Institute Division of Intramural Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Immunology Graduate Program, Tufts University Graduate School of Biomedical Sciences, Boston, Massachusetts; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida.
- Immunology Graduate Program, Tufts University Graduate School of Biomedical Sciences, Boston, Massachusetts.
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York.
- Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida.
- University of Pennsylvania Cardiovascular Institute, Philadelphia, Pennsylvania.
- Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: pilar.alcaide@med.miami.edu.
Förderung
- National Heart Lung and Blood Institute Division of Intramural Research
Zitieren
APA
Zambrano, M. A., Bayer, A. L., Ramos, R. B., Stortini, C., Kaur, K., Bedi, K., Margulies, K. B., & Alcaide, P. (2026). Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2026.08.007
Vancouver
Zambrano MA, Bayer AL, Ramos RB, Stortini C, Kaur K, Bedi K, et al. Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2026.08.007
BibTeX
@article{Zambrano2026,
author = {Zambrano, Maria A and Bayer, Abraham L and Ramos, Ramon B and Stortini, Constanza and Kaur, Kuljeet and Bedi, Kenneth and Margulies, Kenneth B and Alcaide, Pilar},
title = {Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity},
journal = {The American Journal of Pathology},
year = {2026},
doi = {10.1016/j.ajpath.2026.08.007}
}
EUVIMED